Watson Pharmaceuticals confirms FDA denies appeal related to Prochieve Watson Pharmaceuticals confirmed that the FDA denied the company's Formal Dispute Resolution Request related to its pending New Drug Application for Prochieve for the prevention of preterm birth in women with a short cervical length. The company said it intends to review possible options related to the continued pursuit of the NDA. Watson filed its FDRR in August of 2012.
News For WPI From The Last 14 Days
Check below for free stories on WPI the last two weeks.
